Illumina, Inc. vs Johnson Controls International PLC — how do they compare? Illumina, Inc. trades at $184.68 (market cap $27.94B), while Johnson Controls International PLC trades at $140 (market cap $85.03B). The key difference: Johnson Controls International PLC is far larger — about 3× Illumina, Inc.'s market cap, and Johnson Controls International PLC pays a 1.15% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | JCI | |
|---|---|---|
Market Cap | $27.94B | $85.03B |
Sector | Health | Industrials |
52-Week High | $194.33 | $148.21 |
52-Week Low | $91.00 | $103.24 |
Enterprise Value | $29.33B | $93.86B |
Dividend Yield | — | 1.15% |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →